Jan Astermark

1 – 10 of 188

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/af7e247a-381e-4a1c-a1d8-7625b1488a9e?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
…
18
19
next »

2025
Mark Comorbidity and Mortality in Men and Women With Haemophilia in Three Nordic Countries–Comparisons to Matched Controls
Steen Carlsson, Katarina ^LU ; Astermark, Jan ^LU ; Baghaei, Fariba ; Brodin, Elisabeth ; Funding, Eva ; Holmström, Margareta ; Österholm, Klaus ; Bergenstråle, Sofia and Lethagen, Stefan (2025) In Haemophilia 31(3). p.401-411
- Contribution to journal › Article
Mark A plain language summary on indirectly comparing bleeding after valoctocogene roxaparvovec gene therapy to bleeding with emicizumab prophylaxis
Astermark, Jan ^LU ; Buckner, Tyler W. ; Frenzel, Laurent ; Hatswell, Anthony J. ; Hinds, David ; Santos, Sandra ; Klamroth, Robert ; Becker, Tobias and York, Deon (2025) In Expert Review of Hematology 18(3). p.177-193
- Contribution to journal › Article
2024
Mark Low bleeding rates after intramuscular Covid-19 vaccination in patients with haemophilia and von Willebrand disease : Outcome data from the Swedish haemophilia registry
Andersson, Nadine G. ^LU ; Brange, Hannes ; Astermark, Jan ^LU ; Axelsson, Malin ^LU ; Baghaei, Fariba ; Magnusson, Maria ; Olsson, Anna ; Olsson, Elsa ; Ranta, Susanna and Westesson, Linda Myrin , et al. (2024) In Haemophilia 30(5). p.1217-1220
- Contribution to journal › Debate/Note/Editorial
Mark Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B) : 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial
Coppens, Michiel ; Pipe, Steven W. ; Miesbach, Wolfgang ; Astermark, Jan ^LU ; Recht, Michael ; van der Valk, Paul ; Ewenstein, Bruce ; Pinachyan, Karen ; Galante, Nicholas and Quellec, Sandra Le , et al. (2024) In The Lancet Haematology 11(4). p.265-275
- Contribution to journal › Article
Mark Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients
Arvanitakis, Alexandros ^LU ; Jepsen, Caroline ; Andersson, Nadine G. ^LU ; Baghaei, Fariba and Astermark, Jan ^LU (2024) In Haemophilia 30(3). p.671-677
- Contribution to journal › Article
Mark Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study)
Måseide, Ragnhild J. ; Berntorp, Erik ^LU ; Astermark, Jan ^LU ; Olsson, Anna ; Bruzelius, Maria ; Frisk, Tony ; Nummi, Vuokko ; Lassila, Riitta ; Tjønnfjord, Geir E. and Holme, Pål A. (2024) In Haemophilia 30(1). p.98-105
- Contribution to journal › Article
Mark Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)
Måseide, Ragnhild J. ; Berntorp, Erik ^LU ; Astermark, Jan ^LU ; Olsson, Anna ; Bruzelius, Maria ; Frisk, Tony ; Nummi, Vuokko ; Lassila, Riitta ; Strandberg, Karin ^LU and Tjønnfjord, Geir E. , et al. (2024) In Research and practice in thrombosis and haemostasis 8(8).
- Contribution to journal › Article
Mark Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.
Cuker, Adam ; Kavakli, Kaan ; Frenzel, Laurent ; Wang, Jiaan Der ; Astermark, Jan ^LU ; Cerqueira, Monica H. ; Iorio, Alfonso ; Katsarou-Fasouli, Olga ; Klamroth, Robert and Shapiro, Amy D. , et al. (2024) In New England Journal of Medicine 391(12). p.1108-1118
- Contribution to journal › Article
Mark Future needs for continuing innovation in hemophilia : improving outcomes for individuals of all severities, including women and those in resource-constrained regions
Blatný, Jan ; Astermark, Jan ^LU ; Catarino, Cristina ; Dolan, Gerry ; Fijnvandraat, Karin ; Hermans, Cédric ; Holstein, Katharina ; Jiménez-Yuste, Víctor ; Klamroth, Robert and Lavin, Michelle , et al. (2024) In Therapeutic advances in hematology 15.
- Contribution to journal › Scientific review
Mark Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8) : a prospective, multicentre, open-label, randomised, phase 3a trial
Chowdary, Pratima ; Angchaisuksiri, Pantep ; Apte, Shashikant ; Astermark, Jan ^LU ; Benson, Gary ; Chan, Anthony K.C. ; Jiménez Yuste, Victor ; Matsushita, Tadashi ; Høgh Nielsen, Amalie Rhode and Sathar, Jameela , et al. (2024) In The Lancet Haematology 11(12). p.891-904
- Contribution to journal › Article

« previous
1
2
3
4
…
18
19
next »